In contrast to the commonly applied approach of JAK inhibition, we present what we believe to be the first direct STAT5-targeting approach in T-ALL and show that STAT5 and ZAP70 signaling are essential in a subset of human T-ALL. This evidence concerns the gene STAT5A and acute lymphoblastic leukemia.